MediPharm Labs Corp.

A Trusted Global Leader in Purified Cannabis Concentrates

This website contains information about cannabis.
Please enter your birthday to confirm that you are of the legal age to consume cannabis in your province.


INVESTORS
  • MediPharm Labs Corp. on Twitter
  • MediPharm Labs Corp. on Facebook
  • MediPharm Labs Corp. on Instagram
  • MediPharm Labs Corp. on LinkedIn
  • MediPharm Labs Corp. on YouTube
  • About Us
    • Our Pharma Quality Standards
    • About Us
    • Management Team
    • Board of Directors
    • Science Advisory Committee
    • Strategic Alliances
    • Science of Extraction
    • COVID-19
    • Virtual Tour
  • Products & Services
    • White Label Production
    • Bulk Wholesale Offerings
    • MediPharm Brand
    • LABS Cannabis
    • Wayfarer
  • News
    • Press Releases
    • Blog
    • Events
    • In The News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • Financial Results
    • SEDAR
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
    • Customer Service
  • Australia
  • Search  
MediPharm Labs Corp. A Global Leader in Pharma-Quality, Cannabinoid-Based Products

MediPharm Labs Press Releases

News

News

  • Press Releases
  • Blog
  • Events
  • In The News

MediPharm Labs Provides Operational Update and Increases Average Weekly Production of Active Cannabinoid Component to 75 Million Milligrams

Jul 16, 2019

MediPharm Labs Secures 9,000 KG of Dried Cannabis Adding Substantial Private Label Cannabis Extract Production

Jun 27, 2019

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

Jun 24, 2019

MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal

Jun 19, 2019

MediPharm Labs Announces Application to Upgrade Listing to the Toronto Stock Exchange

Jun 18, 2019

MediPharm Labs Announces Closing of $75 Million Bought Deal Financing

Jun 17, 2019

MediPharm Labs Corp. Announces Upsize of Bought Deal Financing to $75 Million

May 29, 2019

MediPharm Labs Announces $60 Million Bought Deal Equity Financing

May 28, 2019

UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction

May 23, 2019

MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control – Establishes Asia-Pacific Foothold

May 21, 2019
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...16
    Next Page
    © 2021 MediPharm Labs Corp. All Rights Reserved. MediPharm Labs Corp.
    151 John St.
    Barrie, ON L4N 2L1
    Canada
    +1 705 719 7425
    Privacy Policy Careers Disclaimer Terms and Conditions Sitemap